Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2012
06/05/2012US8192940 Method for amplifying unknown DNA sequence adjacent to known sequence
06/05/2012US8192939 Universal multi-variant detection system
06/05/2012US8192937 Methods for quantification of microRNAs and small interfering RNAs
06/05/2012US8192936 Polarization-enhanced detector with gold nanorods for detecting nanoscale rotational motion and method therefor
06/05/2012US8192933 Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2)
06/05/2012US8192932 Covalent joining of DNA strands to RNA strands catalyzed by vaccinia topoisomerase
06/05/2012US8192782 Enzymatic oil-degumming method
06/05/2012CA2681966C Baculovirus expression system
06/05/2012CA2496182C Terminal phosphate blocked nucleoside polyphosphates
06/05/2012CA1341630C Transformation vectors allowing expression of foreign polypeptide endotoxins in plants
05/2012
05/31/2012WO2012070968A1 Method for the molecular design and synthesis of therapeutic and preventive drugs
05/31/2012WO2012070965A1 Modified anticomplementary oligonucleotides with anticancer properties and method for producing same
05/31/2012WO2012069059A1 Oligonucleotides for modulation of target rna activity
05/31/2012WO2012068870A1 Ternary complex, liquid containing ternary complex, preparing method and use thereof
05/31/2012WO2012047631A3 Compositions and methods useful for the treatment and diagnosis of inflammatory bowel disease
05/31/2012WO2012026878A8 Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin
05/31/2012WO2007070376A8 Diagnosis, prognosis and monitoring of disease progression of systemic lupus erythematosus through blood leukocyte microarray analysis
05/31/2012WO2005018539A8 Influenza hemagglutinin and neuraminidase variants
05/31/2012US20120137387 Methods for genetic control of insect infestation in plants and compositions thereof
05/31/2012US20120137379 Novel aav's and uses thereof
05/31/2012US20120136145 Compositions and Methods for Inhibiting Expression of Eg5 Gene
05/31/2012US20120136144 Sirna targeting catenin, beta-1 (ctnnb1)
05/31/2012US20120136143 Methods and Kits for Sense RNA Synthesis
05/31/2012US20120136045 Screening for compounds that modulate gpr3-mediated beta-arrestin signaling and amyloid beta peptide generation
05/31/2012US20120136044 Compositions And Methods Of Inhibiting NADPH Oxidase Expression
05/31/2012US20120136043 Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field
05/31/2012US20120136042 Carbohydrate conjugates as delivery agents for oligonucleotides
05/31/2012US20120136040 Hybrid interfering rna
05/31/2012US20120136039 Single nucleotide polymorphism (snp) targeting therapies for the treatment of huntington's disease
05/31/2012US20120135941 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
05/31/2012US20120135912 Polypeptide inhibitors of vla4
05/31/2012US20120135892 siRNA targeting spleen tyrosine kinase
05/31/2012US20120135889 Methods and compositions for improved fertilization and embryonic survival
05/31/2012US20120135885 Methods and Kits Using Extended Rhodamine Dyes
05/31/2012US20120135879 Method and Composition for Cancer Diagnosis and Treatment
05/31/2012US20120135871 High throughput detection of molecular markers based on aflp and high through-put sequencing
05/31/2012US20120135540 Methods and compositions of nucleic acid ligands for detection of clinical analytes related to human health
05/31/2012US20120135521 Antigene locks and therapeutic uses thereof
05/31/2012US20120135516 Artificial antibody polypeptides
05/31/2012US20120135496 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof
05/31/2012US20120135494 Systems and methods for magnetic separation of biological materials
05/31/2012US20120135463 Rhamnose promoter expression system
05/31/2012US20120135459 Novel fluorinated rhodamines as photostable fluorescent dyes for labelling and imaging techniques
05/31/2012US20120135414 Chemically-enhanced primer compositions, methods and kits
05/31/2012US20120135408 Unc-45a splice variants based cancer diagnostics and therapeutics
05/31/2012US20120135397 Human immunodeficiency virus type 1 (hiv-1) detection method and kit therefor
05/31/2012US20120135393 Real-time pcr point mutation assays for detecting hiv-1 resistance to antiviral drugs
05/31/2012US20120135011 Method for in vivo expansion of T regulatory cells
05/31/2012US20120134991 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function
05/31/2012US20120134984 Molecules with extended half-lives and uses thereof
05/31/2012US20120134927 Beta cell marker antibody
05/31/2012CA2818824A1 Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog
05/31/2012CA2818556A1 Nucleotide-based probes and methods for the detection and quantification of macromolecules and other analytes
05/30/2012EP2458013A1 Anti alpha v beta 6 antibodies and uses therof
05/30/2012EP2458012A1 Anti alpha v beta 6 antibodies and uses thereof
05/30/2012EP2457922A1 Altered FAD2 and FAD3 genes in brassica and the molecular marker-assisted detection thereof
05/30/2012EP2064224B1 Tissue culture system for production of hepatitis c virus
05/30/2012EP1343802B1 Process for the preparation of oligonucleotides
05/30/2012CN1798766B Humanized antibodies that recognize beta amyloid peptide
05/30/2012CN102482697A 用于定量生物样品中dna的改良方法 Improved method for the quantitative biological samples for dna
05/30/2012CN102482677A 通过抑制nrf2的天然反义转录物治疗核因子(红细胞衍生2)-样2(nrf2)相关疾病 By inhibiting nrf2 natural antisense transcripts treatment of nuclear factor (RBC-derived 2) - Sample 2 (nrf2) related diseases
05/30/2012CN102482334A Sparc angiogenic domain and methods of use
05/30/2012CN102481310A 牵涉心肌梗死后重塑和心力衰竭的微小rna的鉴定 Identification of remodeling after myocardial infarction and heart failure involves tiny rna of
05/30/2012CN101443022B Use of a growth-stimulating protein
05/30/2012CN101293909B Nucleic acid bionic nano material with electric potential gradient, preparation method and application thereof
05/30/2012CN101291948B Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
05/30/2012CN101289486B Process for synthesizing RNA monomer
05/30/2012CN101259289B Methods and compositions for therapeutic use of RNA interference
05/30/2012CN101148667B Preparation and use for affinity human albumin nucleic acid aptamer
05/30/2012CN101148666B Nucleic acid adapter with high specificity and high affinity to human breast carcinoma tissue, preparation method and application thereof
05/30/2012CN101146818B Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
05/30/2012CN101133074B RNAi modulation of APOB and uses thereof
05/29/2012USRE43425 Mutant prenyl diphosphate synthase
05/29/2012US8188338 Isolated nucleic acid fragments and recombinant constructs; plant cells, transgenic seeds, progeny plants
05/29/2012US8188336 Rice and products thereof having starch with an increased proportion of amylose
05/29/2012US8188335 Δ9-elongase for production of polyunsaturated fatty acid-enriched oils
05/29/2012US8188334 Injecting drosophila embryos
05/29/2012US8188265 Method for the isolation of mRNA from formalin fixed, paraffin-embedded tissue
05/29/2012US8188264 RNAi mediated knockdown of NuMA for cancer therapy
05/29/2012US8188263 Modified siRNA molecules and uses thereof
05/29/2012US8188262 Short interference ribonucleic acids for treating allergic diseases
05/29/2012US8188261 Stabilized immune modulatory RNA (SIMRA) compounds
05/29/2012US8188260 Versatile acylation catalytic RNAs and uses thereof
05/29/2012US8188259 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration
05/29/2012US8188258 Oligonucleotides for amplifying Chlamydophila pneumoniae nucleic acid
05/29/2012US8188257 Direct quantification of ribosome inactivating protein
05/29/2012US8188256 Primer and probe for detection of Mycobacterium intracellulare
05/29/2012US8188255 Human microRNAs associated with cancer
05/29/2012US8188254 C-class oligonucleotide analogs with enhanced immunostimulatory potency
05/29/2012US8188253 Penaeidin gene promoters in tiger shrimp and applications thereof
05/29/2012US8188252 Rad51 derived cancer cell specific promoters for targeted anti-cancer therapy
05/29/2012US8188251 Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
05/29/2012US8188250 Butanol dehydrogenase enzyme from the bacterium Achromobacter xylosoxidans
05/29/2012US8188249 Nucleic acid molecules encoding antibodies to M-CSF
05/29/2012US8188248 Nucleic acids encoding interleukin-12P40 variants with improved stability
05/29/2012US8188247 Conjugates and compositions for cellular delivery
05/29/2012US8188246 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use
05/29/2012US8188245 Enduracidin biosynthetic gene cluster from streptomyces fungicidicus
05/29/2012US8188243 Methods and compositions for the detection of biological molecules using a two particle complex
05/29/2012US8188226 High activity growth factor mutants
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 899